Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: A Study of ADX-102 in Subjects With Allergic Conjunctivitis [Phase 2]
Phase 2 trial of ADX-102 in allergic conjunctivitis completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment [Phase 4]
Phase 4 trial comparing bepotastine 1.5% preservative-free formulation versus olopatadine 0.2% with benzalkonium chloride for allergic conju…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis [Phase 2]
Phase 2 trial evaluating PRT-2761 for allergic conjunctivitis has been completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis [Phase 4]
Phase 4 clinical trial comparing Pataday Once Daily Relief Extra Strength to Flonase Allergy Relief in allergic conjunctivitis has completed…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis [Phase 2]
Phase 2 clinical trial update on Tacrosolv for allergic conjunctivitis and allergic rhinitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis [Phase 4]
Phase 4 trial comparing Pataday Once Daily Relief Extra Strength to Claritin for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: DEXTENZA Therapy for Treatment of Allergic Conjunctivitis [Phase 4]
Phase 4 trial update for DEXTENZA therapy in allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. [Phase 3]
Phase 3 clinical trial evaluating bilastine ophthalmic solution 0.6% in an allergic conjunctivitis model has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model [Phase 2]
Phase 2 clinical trial evaluating bilastine ophthalmic solution for allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating OTX-DP for allergic conjunctivitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis [Phase 2]
Phase 2 trial evaluating ST266 ophthalmic drops versus placebo for allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle [Phase 3]
Phase 3 clinical trial comparing EM-100 to Zaditor and vehicle in allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo [Phase 4]
Phase 4 trial evaluating fluticasone propionate nasal spray versus placebo in allergic rhinitis and allergic conjunctivitis; study completed…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy [Phase 4]
Phase 4 trial evaluating anti-inflammatory effects of Lastacaft in allergic conjunctivitis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study [Phase 2]
Phase 2 clinical trial update for intra-lymphatic immunotherapy targeting tree pollen allergy shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. [Phase 3]
A Phase 3 clinical trial evaluating ketotifen/naphazoline ophthalmic solution for acute allergic conjunctivitis has completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. [Phase 3]
Phase 3 clinical trial update for ketotifen/naphazoline ophthalmic solution in allergic conjunctivitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray [Phase 3]
Phase 3 trial updating demonstration of equivalence and early onset for a novel anti-allergic nasal spray compared to a marketed spray; stud…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients [Phase 2]
Phase 2 trial assessing safety and efficacy of Bepotastine Besilate Ophthalmic Solution for seasonal allergic conjunctivitis completed with …
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers [Phase 3]
A Phase 3 trial evaluating the safety of KetoNaph ophthalmic solution in healthy volunteers for allergic conjunctivitis has completed with r…
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis [Phase 2]
Phase 2 trial update for mapracorat ophthalmic formulation in subjects with allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer [Phase 4]
Phase 4 trial evaluating BEPREVE 1.5% on tear film osmolarity and lipid layer in allergic conjunctivitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis [Phase 2]
Phase 2 trial evaluating PR013 topical ophthalmic drops versus vehicle for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis [Phase 4]
Phase 4 clinical trial comparing Bepreve to Alrex in moderate to severe allergic conjunctivitis; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model [Phase 4]
Phase 4 trial evaluating prednisolone in a modified conjunctival allergen challenge model for chronic allergic conjunctivitis; study complet…